The
market holds a significant growth potential owing to the increasing application
of miRNA sequencing and assay in the healthcare industry. For instance, several
research studies demonstrate that miRNAs can be used as
efficient biomarkers in the diagnosis and prognosis of cancer
(breast, ovarian, cervical, and others), cardiovascular diseases, sepsis, and
nervous system disorders. Therefore, miRNA sequence analysis is increasingly
employed to analyze gene regulation in clinical disorders.
As
plasma from COVID-19 recovered patients is rich in antiviral miRNAs and
antibodies, it has been employed to treat SARS-CoV-2 infected patients. This
has led to an increase in research studies that focus on the sequence analysis
of miRNAs (microRNA) from the patient as well as the virus.
Related Press
Release@ miRNA Sequencing And Assay Market
Report
miRNA Sequencing And Assay Market Report Highlights
- The product
segment dominated the market and accounted for the largest revenue share
in 2020. The commercial presence of multiple players that offer extensive
kits, consumables, and instruments for specialized applications contribute
to segment growth
- Small and
mid-sized research entities face financial limitations to install
sequencing equipment owing to their high cost. Therefore, these
organizations approach service providers. This is expected to drive the
services segment with the fastest CAGR over the forecast period
- Sequencing
by synthesis holds a major share of the technology segment owing to its
high sensitivity, fast turnaround time, and high throughput
- Additionally,
this technology is playing important role in the detection of mutations in
tumor tissue which helps to develop targeted and personalized therapies
- The
sequencing workflow segment held the largest revenue share in 2020 and is
expected to witness the fastest CAGR during the forecast period as it is
the most important and crucial step of the workflow
- The cancer
application segment generated the largest revenue share in 2020 owing to
ongoing extensive research in cancer using miRNA as a biomarker to study
diagnosis and prognosis of cancer and to develop novel therapies
- Furthermore,
an increase in the number of cancer patients globally drives segment
growth
- Research and
academic institutions are one of the major revenue generators of the market
as miRNA sequencing and assay techniques and associated products are being
widely used in various research studies conducted by research and academic
institutes
- In Asia
Pacific, the market is anticipated to register a lucrative growth rate
throughout the forecast owing to the presence of a huge target population,
growing establishment of healthcare, and high unmet clinical needs
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment